 TD Asset Management Inc. acquired a new stake in Cortexyme, Inc. NASDAQ:CRTX in the second quarter, according to the company in its most recent Form 13F filing with the Securities Exchange Commission. The firm acquired 4,400 shares of the biopharmaceutical companys stock, valued at approximately 204,000. Several other large investors also recently made changes ... 